Why I Invested in Beckley Psytech

Cosmo is one founder I’d love to sit in a pub with talking about living in a world of Psychedelic capital to develop clinically validated cannabis-based medicines :)

Beckley Psytech, born out of the Beckley Foundation (involved in the the first brain imaging studies on LSD and psilocybin), is developing a diversified pipeline of psychedelic compounds into licensed pharmaceutical medicines to help patients suffering from both rare and common neuropsychiatric disorders. They have 2 distinct treatment models, and I’m a huge believer in Psychedelic-Assisted Psychotherapy.

There is a huge unmet need to treat psychiatric & neurological disease, with more advances being made in assisted therapies and lately using machine learning to create new chemical entities. The state & federal regulators in the US are starting to warm to these compounds, given Psilocybin is still a Schedule I substance in the US. The science around psychedelic medicine has been around for years, however it’s exciting to see the recent technology advancements in some of these compounds, for instance to treat alcohol disorder.